Cambridge Nutritional Sciences plc (AIM:CNSL)
London · Delayed Price · Currency is GBP · Price in GBX 1.725
-0.025 (-1.43%)
Jul 31, 2026, 4:05 PM GMT
AIM:CNSL Ratios and Metrics
Market cap in millions GBP. Fiscal year is April - March.
Millions GBP. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 4 | 7 | 8 | 7 | 7 | 147 | |
Market Cap Growth | -53.33% | -11.59% | 11.42% | 4.76% | -95.21% | 1181.66% |
Enterprise Value | 1 | 3 | 4 | 5 | 5 | 142 |
Last Close Price | 0.02 | 0.03 | 0.03 | 0.03 | 0.04 | 0.81 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
PE Ratio | 3.05 | 4.63 | - | - | - | - |
Forward PE | - | 260.00 | 260.00 | 260.00 | 260.00 | 260.00 |
PS Ratio | 0.52 | 0.87 | 0.84 | 0.98 | 0.82 | 21.56 |
PB Ratio | 0.38 | 0.64 | 0.85 | 0.74 | 0.60 | 6.29 |
P/TBV Ratio | 0.55 | 0.91 | 1.31 | 1.15 | 0.85 | 7.46 |
P/FCF Ratio | - | - | 14.69 | - | - | - |
P/OCF Ratio | - | - | 13.52 | - | - | - |
PEG Ratio | - | 0.22 | 0.22 | 0.22 | 0.22 | 0.22 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
EV/Sales Ratio | 0.10 | 0.34 | 0.41 | 0.64 | 0.58 | 20.82 |
EV/FCF Ratio | - | - | 7.20 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.03 | 0.02 | 0.01 | 0.03 | 0.12 |
Debt / EBITDA Ratio | - | - | - | - | 2.01 | 25.16 |
Debt / FCF Ratio | - | - | 0.27 | - | - | - |
Net Debt / Equity Ratio | -0.30 | -0.40 | -0.55 | -0.51 | -0.10 | -0.13 |
Net Debt / EBITDA Ratio | 10.30 | 23.06 | 26.48 | 2.11 | 23.75 | 29.55 |
Net Debt / FCF Ratio | 6.21 | 16.02 | -9.47 | 1.59 | 0.29 | 0.68 |
Asset Turnover | 0.62 | 0.61 | 0.69 | 0.47 | 0.36 | 0.28 |
Inventory Turnover | 3.60 | 4.02 | 5.39 | 4.28 | 2.06 | 1.66 |
Quick Ratio | 3.79 | 3.14 | 4.23 | 3.85 | 1.29 | 3.24 |
Current Ratio | 4.25 | 3.62 | 4.67 | 4.29 | 3.12 | 4.01 |
Return on Equity (ROE) | 13.26% | 14.85% | -3.34% | -29.14% | -8.01% | 2.08% |
Return on Assets (ROA) | -2.58% | -1.79% | -2.36% | -10.53% | -1.56% | -1.21% |
Return on Invested Capital (ROIC) | -7.02% | -7.01% | -11.51% | -35.05% | -3.82% | -2.56% |
Return on Capital Employed (ROCE) | -4.90% | -3.40% | -4.40% | -21.80% | -4.10% | -1.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Earnings Yield | 32.78% | 21.58% | -4.00% | -52.39% | -161.13% | -1.43% |
FCF Yield | -12.99% | -3.89% | 6.81% | -43.12% | -59.67% | -2.98% |
Buyback Yield / Dilution | -0.08% | -0.07% | -2.70% | -23.98% | -5.59% | -26.20% |